Chronic Lung Disease in Medical Literature for More Than 200 Years Finally Has Its First Drug

Insmed’s Brinsupri is the first drug specifically approved for treating non-cystic fibrosis bronchiectasis, a progressive and potentially fatal lung disorder. The drug, licensed from AstraZeneca, inhibits activation of neutrophils, white blood cells that play a role in inflammatory and immune responses. The post Chronic Lung Disease in Medical Literature for More Than 200 Years Finally…

Read More

You Can’t Spell Fair Pay Without AI

By KIM BELLARD Everything’s about AI these days. Everything is going to be about AI for a while. Everyone’s talking about it, and most of them know more about it than I do. But there is one thing about AI that I don’t think is getting enough attention. I’m old enough that the mantra “follow…

Read More

KFF/The Washington Post Survey of Parents

The KFF-Washington Post partnership Survey of Parents explores experiences and views pertaining to childhood vaccines. The Survey of Parents also sheds light on school vaccination requirements, views on federal health agencies and policy changes, and the views of parents with children diagnosed with autism spectrum disorder. This poll comes as the Trump administration revamps federal…

Read More

ISPOR 2025 in Montréal

Three panels. One great city. Can’t wait for the conversations at ISPOR 2024 in Montréal. GCEA: Where do we go from here? (14 May, 5-6pm)Should we finally rethink the 3% discount rate? (15 May, 3:15-4:15pm)How can HEOR support providers in value-based care? (16 May, 10-11am)  I’ll be diving into all three — including teaming up with…

Read More

Feeling the Pressure

By MIKE MAGEE After Trump crashed the markets, citizens worldwide are “feeling the pressure.” But in the spirit of calming us down, let’s consider a story of human cooperation and success from our past. It has been estimated that a medical student learns approximately 15,000 new words during the four years of training. One of…

Read More